Date: 2017-10-10
Type of information: Nomination
Compound: vice-president
Company: Blueprint Medicines (USA - MA)
Therapeutic area: Cancer - Oncology - Rare diseases
Type agreement: nomination
Action mechanism:
Disease:
Details:
- • On October 10, 2017, Blueprint Medicines announced the appointment of Christopher Murray as Senior Vice President, Technical Operations. Dr. Murray will join the executive management team and be responsible for technical development, manufacturing and supply chain operations. Dr. Murray joins Blueprint Medicines with over 25 years of commercial and clinical manufacturing experience in the biopharmaceutical industry. Most recently, Dr. Murray served as Vice President, Technical Operations at Ariad Pharmaceuticals from January 2014 to May 2017. In this role, Dr. Murray oversaw all aspects of commercial and clinical manufacturing, supply chain and logistics, process development, quality control and analytical chemistry for Ariad's approved products and product candidates, including Iclusig® (ponatinib) and Alunbrig® (brigatinib). From 2004 to December 2013, Dr. Murray held multiple roles of increasing responsibility at Ariad related to process development, manufacturing and clinical supply. Prior to joining Ariad, Dr. Murray served in various positions with Allos Therapeutics and Hauser related to clinical and commercial manufacturing and supply of active pharmaceutical ingredient. Dr. Murray holds a B.S. from Hope College with a major in chemistry and a Ph.D. in chemistry from the University of Chicago.
Financial terms:
Latest news:
Is general: Yes
